Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1992-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0091-3057(92)90506-BPMID 1475306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term effects of yohimbine on behavioral sensitivity to a stressor

  2004cited by this paper
• Discriminative stimulus properties of pizotifen maleate (BC105): a putative serotonin antagonist

  2004cited by this paper
• Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli

  2004cited by this paper
• The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): Differentiation from amphetamine

  2004cited by this paper
• Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105

  2004cited by this paper
• Autonomic and psychic effects of yohimbine hydrochloride

  2004cited by this paper
• Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.

  1992cited by this paper
• Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.

  1992cited by this paper
• Effects and aftereffects of ibogaine on morphine self-administration in rats.

  1991cited by this paper
• Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.

  1991cited by this paper
• Asymmetrical cross‐generalization in drug discrimination with lorazepam and pentobarbital training conditions

  1989cited by this paper
• Yohimbine and serotonergic agonists: Stimulus properties and receptor binding

  1989cited by this paper
• Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.

  1988cited by this paper
• Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine.

  1988cited by this paper
• Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine.

  1986cited by this paper
• Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).

  1986cited by this paper
• Mechanistic studies on DOM as a discriminative stimulus.

  1985cited by this paper
• Discriminative stimulus properties of the serotonin agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP).

  1984cited by this paper
• The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

  1984cited by this paper
• 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

  1984cited by this paper
• The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.

  1984cited by this paper
• Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

  1984cited by this paper
• Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.

  1983cited by this paper
• A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.

  1982cited by this paper
• The pharmacological basis of therapeutics. 6th ed: By Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. 1843 pp., $45.00. Macmillan Publishing Co., Inc., New York, New York, 1980

  1981cited by this paper
• Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

  1981cited by this paper
• A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.

  1980cited by this paper
• Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.

  1979cited by this paper
• Drug discrimination and state dependent learning

  1978cited by this paper
• Drug-Induced Stimulus Control

  1978cited by this paper
• Hallucinogen binding to dopamine/neuroleptic receptors

  1977cited by this paper
• A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat

  1975cited by this paper
• Drug addiction and drug abuse in Korea.

  1974cited by this paper
• Psychotropic properties of the harmala alkaloids

  1967cited by this paper
• Biostatistics -- An Introductory Text

  1965cited by this paper
• A psycho-pharmacological study of some indole alkaloids.

  1962cited by this paper
• Psychotomimetic drugs; chemical and pharmacological aspects.

  1959cited by this paper
• NEUROPHARMACOLOGICAL STUDIES ON IBOGAINE, AN INDOLE ALKALOID WITH CENTRAL‐STIMULANT PROPERTIES

  1957cited by this paper

• Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders

  2023cites this paper
• UPDATES AND ADDITIONS for Herbal Contraindications &Drug Interactions plus Herbal Adjuncts with Medicines

  2016cites this paper
• Discriminative Stimulus Properties of Receptor Antagonists

  2011cites this paper
• Ibogaine and Noribogaine: Comparing Parent Compound to Metabolite

  2006cites this paper
• lbogaine and Cocaine Abuse : Pharmacological Interactions at Dopamine and Serotonin Receptors

  2003cites this paper
• Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener.

  2001cites this paper
• Drug discrimination studies with ibogaine.

  2001cites this paper
• Chapter 4 Drug discrimination studies with ibogaine

  2001cites this paper
• Characterization of multiple sites of action of ibogaine.

  2001cites this paper
• The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.

  2000cites this paper
• Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments.

  2000cites this paper
• The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.

  1999cites this paper
• Chapter 3 - Pharmacology of Ibogaine and Ibogaine-Related Alkaloids

  1999cites this paper
• Noribogaine Generalization to the Ibogaine Stimulus: Correlation with Noribogaine Concentration in Rat Brain

  1999cites this paper
• Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.

  1999cites this paper
• Mechanisms of Antiaddictive Actions of Ibogaine a

  1998cites this paper
• Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.

  1998cites this paper
• Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys.

  1998cites this paper
• Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.

  1998cites this paper
• Mechanisms of antiaddictive actions of ibogaine.

  1998cites this paper
• Effects of ibogaine on performance in the 8-arm radial maze.

  1997cites this paper
• The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus.

  1997cites this paper
• NOS and fos in Rat and Mouse Brain Regions

  1996cites this paper
• Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats.

  1995cites this paper
• Determination of ibogaine and 12-hydroxy-ibogamine in plasma by gas chromatography-positive ion chemical ionization-mass spectrometry.

  1995cites this paper
• 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

  1995cites this paper
• The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents

  1995influential citation
• Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity.

  1995cites this paper
• Interactions of clozapine with the stimulus effects of DOM and LSD.

  1994cites this paper
• Ibogaine modulates cocaine responses which are altered due to environmental habituation: In vivo microvoltammetric and behavioral studies☆

  1994cites this paper